Healthcare professionals' knowledge, confidence and perceptions of pharmacogenomics in primary care and pain management

被引：6

作者：

Behr, Matthew P. ^{[1
]}

Gammal, Roseann S. ^{[1
]}

Matthews, Michele L. ^{[1
,2
]}

Wang, Victor C. ^{[3
]}

机构：

[1] Massachusetts Coll Pharm & Hlth Sci, Dept Pharm Practice, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Pain Management Ctr, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Neurol, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA

来源：

PHARMACOGENOMICS | 2023年

关键词：

pain management; personalized patient care plan; pharmacogenomics; primary care; survey; PHYSICIANS; SUPPORT;

D O I：

10.2217/pgs-2023-0028

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Aim: To assess knowledge, confidence and perceptions of healthcare professionals specializing in primary care and pain management at Brigham and Women's Hospital, related to clinical pharmacogenomics (PGx). Methods: A 25-question online survey was distributed to 328 Brigham and Women's Hospital clinicians for analysis. Results: Thirty-four clinicians completed the survey. Respondents had minimal experience with PGx and limited awareness of PGx resources. Although respondents expressed belief that PGx has utility to improve medication-related patient outcomes, many lack confidence to apply PGx results to their practice. For clinical drug-gene questions relevant to primary care and/or pain management, respondents scored poorly. Conclusion: More clinician education is needed for appropriate utilization of PGx in clinical practice as it pertains to primary care and pain management.

引用

页码：371 / 379

页数：9

共 24 条

[1] Ethiopian health care professionals' knowledge, attitude, and interests toward pharmacogenomics [J].

Abdela, Ousman Abubeker ;

Bhagavathula, Akshaya Srikanth ;

Gebreyohannes, Eyob Alemayehu ;

Tegegn, Henok Getachew .

PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 :279-285

[2]

Center for Drug Evaluation and Research US FDA, 2022, TABLE PHARMACOGENOMI

[3] Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy [J].

Crews, Kristine R. ;

Monte, Andrew A. ;

Huddart, Rachel ;

Caudle, Kelly E. ;

Kharasch, Evan D. ;

Gaedigk, Andrea ;

Dunnenberger, Henry M. ;

Leeder, J. Steven ;

Callaghan, John T. ;

Samer, Caroline Flora ;

Klein, Teri E. ;

Haidar, Cyrine E. ;

Van Driest, Sara L. ;

Ruano, Gualberto ;

Sangkuhl, Katrin ;

Cavallari, Larisa H. ;

Muller, Daniel J. ;

Prows, Cynthia A. ;

Nagy, Mohamed ;

Somogyi, Andrew A. ;

Skaar, Todd C. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (04) :888-896

[4] Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers [J].

Dunnenberger, Henry M. ;

Crews, Kristine R. ;

Hoffman, James M. ;

Caudle, Kelly E. ;

Broeckel, Ulrich ;

Howard, Scott C. ;

Hunkler, Robert J. ;

Klein, Teri E. ;

Evans, William E. ;

Relling, Mary V. .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55, 2015, 55 :89-+

[5] Expanding evidence leads to new pharmacogenomics payer coverage [J].

Empey, Philip E. ;

Pratt, Victoria M. ;

Hoffman, James M. ;

Caudle, Kelly E. ;

Klein, Teri E. .

GENETICS IN MEDICINE, 2021, 23 (05) :830-832

[6] Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams [J].

Gammal, Roseann S. ;

Berenbrok, Lucas A. ;

Empey, Philip E. ;

Massart, Mylynda B. .

JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12)

[7] Ready or not, here it comes: Direct-to-consumer pharmacogenomic testing and its implications for community pharmacists [J].

Gammal, Roseann S. ;

Mayes, Jason ;

Caudle, Kelly E. .

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2019, 59 (05) :646-650

[8]

Guidelines, 2021, GUIDELINES

[9] Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update [J].

Hicks, J. K. ;

Sangkuhl, K. ;

Swen, J. J. ;

Ellingrod, V. L. ;

Muller, D. J. ;

Shimoda, K. ;

Bishop, J. R. ;

Kharasch, E. D. ;

Skaar, T. C. ;

Gaedigk, A. ;

Dunnenberger, H. M. ;

Klein, T. E. ;

Caudle, K. E. ;

Stingl, J. C. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (01) :37-44

[10] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors [J].

Hicks, J. K. ;

Bishop, J. R. ;

Sangkuhl, K. ;

Mueller, D. J. ;

Ji, Y. ;

Leckband, S. G. ;

Leeder, J. S. ;

Graham, R. L. ;

Chiulli, D. L. ;

LLerena, A. ;

Skaar, T. C. ;

Scott, S. A. ;

Stingl, J. C. ;

Klein, T. E. ;

Caudle, K. E. ;

Gaedigk, A. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (02) :127-134

← 1 2 3 →